Company News
Sunresin Selected for Morgan Stanley’s “China Best Business Models 2.0” List, Recognized for Strong Competitive Advantages
Sunresin (300487.SZ), a global leader in adsorption and separation materials, has been selected for Morgan Stanley’s “China Best Business Models 2.0” list.
Sunresin Establishes Subsidiary in Sweden to Strengthen Global Life Sciences Strategy
Sunresin is pleased to announce the establishment of its new subsidiary and European Regional Headquarters for Life Sciences in Sweden.
Sunresin Bioprocess Materials Achieve DMF Registration, Supporting Global Biopharma Compliance
Sunresin has obtained 10 Drug Master File (DMF) registrations for its chromatography resins used in antibody, vaccine, and gene therapy production. With 9 more products under review, Sunresin provides robust regulatory support for global pharmaceutical customers and accelerates IND/NDA filing efficiency with FDA and EMA compliance.
Sunresin Secures Australian Patent for Lithium Adsorbent Innovation
Sunresin New Materials Co., Ltd. is pleased to announce that its invention titled “A Lithium Adsorbent and Its Preparation Method” has been officially granted a patent in Australia.
SZSE Visits Sunresin – An ETF Constituent Company in the CSI 500 Index
On the morning of March 28, the Shenzhen Stock Exchange (SZSE), along with representatives from Harvest Fund and over 30 other participants, visited Sunresin— a constituent company of the CSI 500 Index — for a special research and engagement activity.
Company
Product
Application
Contact Us
Sunresin Park,No.135, jinye Road, Xi’an Hi-tech Industrial Development Zone, Shaanxi-710076, China
seplite@sunresin.com
seplite_europe@sunresin.com
+86-29-89182091